These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3015853)

  • 21. Use of penicillinase-resistant penicillins to increase the susceptibility of gram-negative bacteria to antibiotics.
    Farrar WE; O'Dell NM; Krause JM
    Ann Intern Med; 1967 Oct; 67(4):733-43. PubMed ID: 4862467
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide.
    Gottstein WJ; Crast LB; Graham RG; Haynes UJ; McGregor DN
    J Med Chem; 1981 Dec; 24(12):1531-4. PubMed ID: 6273562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli.
    Brenner DG; Knowles JR
    Biochemistry; 1984 Nov; 23(24):5839-46. PubMed ID: 6098300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    Bonomo RA; Rudin SA; Shlaes DM
    FEMS Microbiol Lett; 1997 Mar; 148(1):59-62. PubMed ID: 9066111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylene (2S,5R)-6-(3-formylallylidene)penicillanate pivalate, a prodrug of a new beta-lactamase inhibitor.
    Adam S; Then R; Angehrn P
    J Antibiot (Tokyo); 1992 Apr; 45(4):587-8. PubMed ID: 1317369
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis and beta-lactamase inhibitory activities of some clavulanic acid analogues.
    Mak CP; Prasad K; Turnowsky F
    J Antibiot (Tokyo); 1983 Apr; 36(4):398-406. PubMed ID: 6602120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
    Campoli-Richards DM; Brogden RN
    Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and beta-lactamase inhibitory activity of 6-[(1-heteroarylthioethyl-1,2,3-triazol-4-yl)-methylene]penam sulfones.
    Im C; Maiti SN; Micetich RG; Daneshtalab M; Atchison K; Phillips OA; Kunugita C
    J Antibiot (Tokyo); 1994 Sep; 47(9):1030-40. PubMed ID: 7928691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of TEM-1 beta-lactamase by 6-acetylmethylenepenicillanic acid.
    Arisawa M; Then R
    Biochem J; 1983 Mar; 209(3):609-15. PubMed ID: 6307259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timentin and beta-lactamases.
    Labia R; Morand A; Péduzzi J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():17-26. PubMed ID: 3487538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships of 6-(heterocyclyl)-methylene penam sulfones; a new class of beta-lactamase inhibitors.
    Chen YL; Chang CW; Hedberg K; Guarino K; Welch WM; Kiessling L; Retsema JA; Haskell SL; Anderson M; Manousos M
    J Antibiot (Tokyo); 1987 Jun; 40(6):803-22. PubMed ID: 3497142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms.
    Sakamoto M; Ishikura T; Fukagawa Y
    J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiological properties of sulbactam combined with ampicillin.
    Barba D; Galante D; Esposito S; Ruffilli MP
    Chemioterapia; 1987 Apr; 6(2):88-94. PubMed ID: 3036381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
    Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro evaluation of sulbactam, a penicillanic acid sulphone with beta-lactamase inhibitory properties.
    Greenwood D; Eley A
    J Antimicrob Chemother; 1982 Aug; 10(2):117-23. PubMed ID: 6288651
    [No Abstract]   [Full Text] [Related]  

  • 38. In-vitro activity of the combinations of ampicillin with mecillinam or with beta-lactamase inhibitors against strains resistant to ampicillin.
    Verbist L
    J Antimicrob Chemother; 1985 Dec; 16(6):719-25. PubMed ID: 3879248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].
    Blahová J; Hupková M; Krcméry V
    Cas Lek Cesk; 1995 Sep; 134(17):558-61. PubMed ID: 7553760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assays of sulbactam in the presence of ampicillin.
    Foulds G; Gans DJ; Girard D; Whall TJ
    Ther Drug Monit; 1986; 8(2):223-7. PubMed ID: 3014686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.